Purpose This study aimed to evaluate the prognostic impact of lymphovascular invasion (LVI) in patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC). Materials and Methods We collected data from 180 patients who were treated with RNU from 2005 to 2013 at our institution. The Kaplan-Meier method with log-rank test and Cox proportional hazards regression models were used for univariate and multivariate analyses. Results LVI was present in 28 patients (15.6%), which was associated with higher pathological tumor stage ( p <0.001), tumor necrosis ( p =0.012), lymph node metastasis ( p =0.017) and multifocality ( p =0.012). On multivariate analysis, LVI was an independent prognostic factor of recurrence-free survival [RFS: hazard ratio (HR)=2.954; 95% confidence interval (CI)=1.539–5.671; p =0.001] and cancer-specific survival (CSS: HR=3.530; 95% CI=1.701–7.325; p =0.001) in all patients. In patients with node-negative UTUC, LVI was also a significant predictor of RFS (HR=3.732; 95% CI 1.866–7.464; p <0.001) and CSS (HR=3.825; 95% CI=1.777–8.234; p =0.001). Conclusion LVI status was an independent predictor in patients with UTUC who underwent RNU. The estimate of LVI could help physicians identify high-risk patients and make a better medication regimen of adjuvant chemotherapy.